Deconstructing Comp
Now in Season 6! We are still breaking down complex workers' compensation issues into bite-sized nuggets, one conversation at a time, with one slight twist. We are finally doing what we set out to do when we started: discuss the nuances of our fascinating system in "Cliff Notes" style summaries.
Yvonne Guibert and Rafael Gonzalez approach workers' comp conversations from different backgrounds. Still, they share many things in common, such as their love for family and friends, a passion for Latin culture, and good old-fashioned belly laughs. Join them as they chat with industry friends and colleagues, learn more about their roles, laugh, and have fun along the way. You might learn something along the way! See you soon! ¡Hasta pronto!
Deconstructing Comp
Dr. Robert Hall: What Our Rx Data Reveals
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
Guest Bio
Dr. Robert Hall | Medical Director, Optum Workers' Comp and Auto No-Fault
- 12 years leading medical direction and formulary oversight at Optum
- Physical medicine and rehabilitation (PM&R) specialist maintaining active clinical practice one day per week with injured workers
- Strategic voice on PBM industry trends, emerging drug therapies, and AI's role in claims prioritization
Our Conversation
We explore pharmacy spending trends, compensability questions around new medications like GLP-1s and migraine medications, and how AI can help claims professionals prioritize without replacing judgment. Our conversation builds on CompPharma's 20th Annual Survey released earlier this year. Dr. Hall provided context from his unique PBM perspective.
See the CompPharma 2025 Prescription Drug Management in Workers' Compensation Survey
Key Discussion Points
Script Volume Down, Per-Script Costs Up
Prescriptions filled decreased 4%, yet per-script costs rose 6%. Fewer generic opioids are available, forcing providers to transition patients to more expensive alternatives. When lower-cost options aren't working, switching to higher-cost versions becomes the default.
Opioid Decline Slowing
Opioid spend dropped 7%—slower than the 13% annual declines of prior years. While fewer people are on opioids overall, those taking them can face additional complications such as opioid-induced hyperalgesia, where the pain medication itself makes pain worse. Providers unknowingly increase doses thinking pain is worsening, creating a spiral that drives costs and complexity.
Efficiency Remains the Industry's Biggest Gap
According to Dr. Hall, despite much progress, feedback from injured workers and treating providers is consistent: speed remains a big issue. Authorization turnarounds, surgery approvals, and medication approvals all lag. Efficiency directly impacts outcomes.
GLP-1s: Compensability Questions Without Clear Answers
GLP-1 medications (weight loss drugs) are appropriate when weight loss is necessary for surgery or when catastrophic injuries cause weight gain. But with 30-40% of adults overweight or obese, there's a strong incentive to route these expensive drugs through workers' comp claims instead of out-of-pocket.
The core tension: just because a drug is medically effective doesn't make it work-related. Clear frameworks are needed to distinguish compensable uses from general health expenses.
A parallel exists with migraine medications—highly effective for a common condition (10% of the population), creating similar pressure to tie them to workers' comp when they may not be compensable.
Important caveat: GLP-1s carry real risks. Severe nausea, vomiting, diarrhea, pancreatitis, and hospitalizations have occurred. When complications arise, they become part of the claim, adding complexity and cost.
PBMs Score Highest on Customer Service
PBMs earned their strongest-ever customer service grades in this year's CompPharma survey. Relationships matter as much as technology. Speed, communication, and partnership mindset drive loyalty.
AI Adoption Rising—But De-skilling Risk Is Real
About one-third of respondents now use AI tools. The cautionary tale: radiologists improved cancer detection with AI, but their standalone diagnostic ability declined after using it.
For workers' comp, AI's highest value is prioritization—flagging the 2 catastrophic claims out of 100 that need immediate attention. The goal is to free human judgment for complex decisions, not replace it. We need to keep using and challenging our brains.
Early Identification of Catastrophic Claims
AI could synthesize accident type, injury location, physician findings, diagnostic studies, and functional capacity to identify claims spiraling toward permanent total or catastrophic status before they explode in cost. Early intervention changes trajectory.
The risk: "creeping catastrophic" claims. Injuries that seem manageable but don't close gradually become complex and expensive. Opioid dosing spirals, high-cost alternatives accumulate, and routine claims become catastrophic without anyone realizing when the shift happened.
State Variations as a Learning Opportunity
For folks newer to workers' comp, Dr. Hall suggests the 50 different state regulatory frameworks aren't just learning obstacles—they're live experiments in how to approach injury treatment. Professionals entering the industry should embrace this complexity and diversity to build deeper medical and operational knowledge.
Human Touch: The Motorcycle Pivot
Dr. Hall learned to ride a motorcycle last year after walking away from the idea a decade ago (when a bike cost as much as new kitchen cabinets). He's now ridden 1,000 miles on quiet Sunday afternoons.
¡Muchas Gracias! Thank you for listening. We would appreciate you sharing our podcast with your friends on social media. Find Yvonne and Rafael on Linked In or follow us on Twitter @deconstructcomp